CUSIP: G9495L109
What is CUSIP G9495L109?
CUSIP G9495L109 identifies VRAX - VIRAX BIOLABS GROUP LTD SHS NEW - Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Open recent reporting periods for CUSIP G9495L109:
As of 31 Dec 2025, 1 institutional investors reported holding 21 shares of VIRAX BIOLABS GROUP LTD SHS NEW - Stock (VRAX).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 21 | $7 | $0.33 | 1 | |
| 2025 Q3 | 21 | $13 | +$13 | $0.62 | 1 |
| 2023 Q4 | 0 | $0 | -$10,891 | $0.33 | 0 |
| 2023 Q3 | 33,509 | $10,891 | -$11,742 | $0.32 | 4 |
| 2023 Q2 | 57,338 | $22,763 | -$1,110,521 | $0.39 | 4 |
| 2023 Q1 | 1,643,242 | $1,140,856 | +$1,011,595 | $0.69 | 5 |
| 2022 Q4 | 184,903 | $132,616 | -$21,287 | $0.72 | 7 |
| 2022 Q3 | 58,373 | $183,000 | +$183,000 | $3.13 | 4 |